US Bancorp DE Cuts Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

US Bancorp DE lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 286,462 shares of the company's stock after selling 9,920 shares during the quarter. US Bancorp DE owned approximately 0.06% of GE HealthCare Technologies worth $22,396,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of GEHC. LGT Financial Advisors LLC increased its position in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies during the third quarter valued at $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter valued at $26,000. Darwin Wealth Management LLC bought a new position in GE HealthCare Technologies during the third quarter valued at $31,000. Finally, Continuum Advisory LLC increased its position in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Up 0.2 %

Shares of NASDAQ:GEHC traded up $0.15 during trading on Thursday, reaching $84.91. The stock had a trading volume of 1,999,776 shares, compared to its average volume of 2,909,880. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a market capitalization of $38.83 billion, a P/E ratio of 19.60, a PEG ratio of 3.19 and a beta of 1.15. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm's 50-day simple moving average is $86.52 and its 200 day simple moving average is $86.13.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analysts Set New Price Targets

GEHC has been the topic of a number of analyst reports. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.